These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 12877406)
1. Neuropsychological performance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits. Nielen MM; Den Boer JA Psychol Med; 2003 Jul; 33(5):917-25. PubMed ID: 12877406 [TBL] [Abstract][Full Text] [Related]
2. Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit. Fontenelle LF; Mendlowicz MV; Versiani M Psychol Med; 2004 Jan; 34(1):181; author reply 181-3. PubMed ID: 14971639 [No Abstract] [Full Text] [Related]
4. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. van den Heuvel OA; Veltman DJ; Groenewegen HJ; Cath DC; van Balkom AJ; van Hartskamp J; Barkhof F; van Dyck R Arch Gen Psychiatry; 2005 Mar; 62(3):301-9. PubMed ID: 15753243 [TBL] [Abstract][Full Text] [Related]
5. Cognitive deficits in obsessive-compulsive disorder on tests of frontal-striatal function. Purcell R; Maruff P; Kyrios M; Pantelis C Biol Psychiatry; 1998 Mar; 43(5):348-57. PubMed ID: 9513750 [TBL] [Abstract][Full Text] [Related]
6. Neuropsychological function in obsessive-compulsive disorder: effects of comorbid conditions on task performance. Aycicegi A; Dinn WM; Harris CL; Erkmen H Eur Psychiatry; 2003 Aug; 18(5):241-8. PubMed ID: 12927325 [TBL] [Abstract][Full Text] [Related]
7. The neuropsychology of the schizo-obsessive subtype of schizophrenia: a new analysis. Patel DD; Laws KR; Padhi A; Farrow JM; Mukhopadhaya K; Krishnaiah R; Fineberg NA Psychol Med; 2010 Jun; 40(6):921-33. PubMed ID: 19818202 [TBL] [Abstract][Full Text] [Related]
8. Differences in neuropsychological performance between subtypes of obsessive-compulsive disorder. Nedeljkovic M; Kyrios M; Moulding R; Doron G; Wainwright K; Pantelis C; Purcell R; Maruff P Aust N Z J Psychiatry; 2009 Mar; 43(3):216-26. PubMed ID: 19221910 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder. Sayyah M; Boostani H; Pakseresht S; Malayeri A Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):362-5. PubMed ID: 20035818 [TBL] [Abstract][Full Text] [Related]
11. Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls. Purcell R; Maruff P; Kyrios M; Pantelis C Arch Gen Psychiatry; 1998 May; 55(5):415-23. PubMed ID: 9596044 [TBL] [Abstract][Full Text] [Related]
12. Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit. Fontenelle LF; Mendlowicz MV; Versiani M Psychol Med; 2004 Oct; 34(7):1367-8; author reply 1368-9. PubMed ID: 15697063 [No Abstract] [Full Text] [Related]
13. Olfactory identification deficits and associated response inhibition in obsessive-compulsive disorder: on the scent of the orbitofronto-striatal model. Bersani G; Quartini A; Ratti F; Pagliuca G; Gallo A Psychiatry Res; 2013 Nov; 210(1):208-14. PubMed ID: 23870490 [TBL] [Abstract][Full Text] [Related]
14. Attention and cognition in patients with obsessive-compulsive disorder. de Geus F; Denys DA; Sitskoorn MM; Westenberg HG Psychiatry Clin Neurosci; 2007 Feb; 61(1):45-53. PubMed ID: 17239038 [TBL] [Abstract][Full Text] [Related]
15. Cognitive performance in children and adolescents at high-risk for obsessive-compulsive disorder. Bernardes ET; Saraiva LC; E Souza MM; Hoexter MQ; Chacon P; Requena G; Miguel EC; Shavitt RG; Polanczyk GV; Cappi C; Batistuzzo MC BMC Psychiatry; 2020 Jul; 20(1):380. PubMed ID: 32690046 [TBL] [Abstract][Full Text] [Related]
16. Cognitive performance of youth with primary generalized anxiety disorder versus primary obsessive-compulsive disorder. Kim KL; Christensen RE; Ruggieri A; Schettini E; Freeman JB; Garcia AM; Flessner C; Stewart E; Conelea C; Dickstein DP Depress Anxiety; 2019 Feb; 36(2):130-140. PubMed ID: 30375085 [TBL] [Abstract][Full Text] [Related]
17. Working memory dysfunction in obsessive-compulsive disorder: a neuropsychological and functional MRI study. Nakao T; Nakagawa A; Nakatani E; Nabeyama M; Sanematsu H; Yoshiura T; Togao O; Tomita M; Masuda Y; Yoshioka K; Kuroki T; Kanba S J Psychiatr Res; 2009 May; 43(8):784-91. PubMed ID: 19081580 [TBL] [Abstract][Full Text] [Related]
18. Effects of chronic fluoxetine treatment on serotonin 1B receptor-induced deficits in delayed alternation. Woehrle NS; Klenotich SJ; Jamnia N; Ho EV; Dulawa SC Psychopharmacology (Berl); 2013 Jun; 227(3):545-51. PubMed ID: 23377022 [TBL] [Abstract][Full Text] [Related]
19. Fluoxetine in the treatment of Huntington's disease. De Marchi N; Daniele F; Ragone MA Psychopharmacology (Berl); 2001 Jan; 153(2):264-6. PubMed ID: 11205429 [TBL] [Abstract][Full Text] [Related]
20. Cognitive deficits of executive functions and decision-making in obsessive-compulsive disorder. Dittrich WH; Johansen T Scand J Psychol; 2013 Oct; 54(5):393-400. PubMed ID: 23841985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]